Gyrolab^® News

02/05/2025

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

11/28/2024

A workplace that attracts

06/18/2024

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

05/09/2024

Regarding transfer of Gyros Protein Technologies headquarter to a new facility

03/27/2024

Gyros Protein Technologies Introduces New Gyrolab CRO Certification Program for Qualifying CRO Partners

09/20/2023

Celebrating 20 years of a remarkable Gyrolab journey!

05/02/2023

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

11/29/2022

Gyros Protein Technologies adds Gyrolab® Biomarker Kits to expand range of ready-to-use kits and reagents

09/30/2021

Gyros Protein Technologies introduces Gyrolab AAV9 Titer Kit to support AAV-based cell and gene therapy production

07/07/2021

Gyros Protein Technologies and Cygnus Technologies introduce HEK 293 HCP Solution for Gyrolab

01/27/2021

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

09/02/2020

Gyros Protein Technologies introduces Gyrolab AAVX Titer Kit to support cell and gene therapy market

03/16/2020

Gyrolab Technology to be incorporated into Jefferson Institute for bioprocessing specialized teaching curriculum and training programs

12/05/2019

VolitionRx and Gyros Protein Technologies awarded an aggregate $1 million+ Eurostars cash grant to collaborate on developing a lung cancer blood test

10/31/2019

Mesa Labs acquires Gyros Protein Technologies

09/09/2019

Gyros Protein Technologies introduces Gyrolab p24 Kit to support the cell and gene therapy market

06/13/2019

Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics